SEARCH

SEARCH BY CITATION

References

  • 1
    Cameron AJ. Epidemiology of columnar-lined esophagus and adenocarcinoma. Gastroenterol Clin North Am 1997; 26: 48794.
  • 2
    Engel LS, Chow WH, Vaughan TL, et al. Population attributable risks of esophageal and gastric cancers. J Natl Cancer Inst 2003; 95: 140413.
  • 3
    Spechler JS. Barrett's esophagus. N Engl J Med 2002; 346: 83642.
  • 4
    Shaheen N, Ransohoff DF. Gastroesophageal reflux. Barrett esophagus and esophageal cancer. JAMA 2002; 287: 197281.
  • 5
    Wang KK, Sampliner RE. Updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett's esophagus. Am J Gastroenterol 2008; 103: 78897.
    Direct Link:
  • 6
    Sontag SJ, Chefjec G, Stanley MM, et al. Barrett's Oesophagus and colonic tumours. Lancet 1985; 1: 9469.
  • 7
    Howden CW, Hornung CA. A systematic review of the association between Barrett's esophagus and colon neoplasms. Am J Gastroenterol 1995; 90: 18149.
  • 8
    Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of Observational Studies in Epidemiology (MOOSE) Group. Meta-analysis of observational studies in epidemiology: a proposal for reporting. JAMA 2000; 283: 200812.
  • 9
    Achkar JP, Post AB, Achkar E, Carey WD. Risk of extraesophageal malignancy in patients with adenocarcinoma arising in Barrett's esophagus. Am J Gastroenterol 1995; 90: 3943.
  • 10
    Bollschweiler E, Schloesser T, Leers J, Vallbohmer D, Schafer H, Holscher AH. High prevalence of colonic polyps in white males with esophageal adenocarcinoma. Dis Colon Rectum 2009; 52: 299304.
  • 11
    Lagergren J, Nyren O. No association between colon cancer and adenocarcinoma of the oesophagus in a population based cohort study in Sweden. Gut 1999; 44: 81921.
  • 12
    Vaughan TL, Kiemeney LA, McKnight B. Colorectal cancer in patients with esophageal adenocarcinoma. Cancer Epidemiol Biomarkers Prev 1995; 4: 937.
  • 13
    Cook MB, Wild CP, Everett SM, et al. Risk of mortality and cancer incidence in Barrett's esophagus. Cancer Epidemiol Biomarkers Prev 2007; 16: 20906.
  • 14
    de Jonge PJF, van Blankenstein M, Looman CWN, Casparie MK, Meijer GA, Kuipers EJ. Risk of colorectal cancer in patients with Barrett ‘s esophagus: a dutch population-based study. Am J Gastroenterol 2010; 105: 7783.
  • 15
    Murphy SJ, Anderson LA, Mainie I, et al. Incidence of colorectal cancer in a population-based cohort of patients with Barrett's Oesophagus. Scand J Gastroenterol 2005; 40: 144953.
  • 16
    Poorman JC, Lieberman DA, Ippoliti AF, Weber LJ, Weinstein WM. The prevalence of colonic neoplasia in patients with Barrett's esophagus: prospective assessment in patients 50–80 years old. Am J Gastroenterol 1997; 92: 5926.
  • 17
    DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 17788.
  • 18
    Elli L, Somalvico F, Rivolta R, Fregoni F. Association between upper and lower gastrointestinal tract lesions. Dig Liver Dis 2010; 42S: S61192.
  • 19
    Limburg PJ, Ahlquist DA, Talley NJ, Cameron AJ, Zinsmeister AR. Risk and site predominance of colorectal cancer with Barrett's esophagus: a cohort study. Gastroenterology 1984; 106: A409.
  • 20
    Lyons MF, Tsuchida AM, Schlepp GE, Pearce WA, Peller TP. Barrett's esophagus (BE) is associated with colon cancer compared to gastroesophageal reflux with stricture (GER/S). Gastroenterology 1993; 104: A139.
  • 21
    Rothstein RI, Smith RG, Power GC. Barrett's esophagus and colonic neoplasia. Gastroenterology 1991; 100: A150.
  • 22
    Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003; 327: 55760.
  • 23
    Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315: 62934.
  • 24
    Cauvin JM, Goldfain D, Le Rhun M, et al. Multicentre prospective controlled study of Barrett's Oesophagus and colorectal adenomas. Lancet 1995; 346: 13914.
  • 25
    Gerson LB, Shetler K, Triadafilopoulos G. Prevalence of Barrett's esophagus in asymptomatic individuals. Gastroenterology 2002; 123: 4617.
  • 26
    Laitakari R, Laippala P, Isolauri J. Barrett's Oesophagus in not a risk factor for colonic neoplasia: a case-control study. Ann Med 1995; 27: 499502.
  • 27
    Robertson DAF, Ayres RCS, Smith CL. Screening for colonic cancer in patients with Barrett's Oesophagus. Br Med J 1989; 298: 650.
  • 28
    Siersema PD, Yu S, Sahbaie P, et al. Colorectal neoplasia in veterans is associated with Barrett's esophagus but not with proton-pump inhibitor or aspirin/NSAID use. Gastrointest Endosc 2006; 63: 5816.
  • 29
    Solaymani-Dodaran M, Logan RF, West J, Card T, Coupland C. Risk of extra-oesophageal malignancies and colorectal cancer in Barrett's Oesophagus and gastro-oesophageal reflux. Scand J Gastroenterol 2004; 39: 6805.
  • 30
    Post AB. Re: Barrett's esophagus and colonic neoplasms. Am J Gastroenterol 1996; 91: 10567 (letter).
  • 31
    Logan RA, Skelly MM. Barrett's Oesophagus and colorectal neoplasia: scope for screening? Gut 1999; 44: 7756.
  • 32
    Levin B, Lieberman DA, McFarland B, et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology 2008; 134: 157095.
  • 33
    Smith RA, Cokkinides V, Eyre HJ. American Cancer Society guidelines for the early detection of cancer, 2005. CA Cancer J Clin 2006; 56: 1125.
  • 34
    El-Serag HB, Kvapil P, Hacken-Bitar J, Kramer JR. Abdominal Obesity and the Risk of Barrett's Esophagus. Am J Gastroenterol 2005; 100: 21516.
    Direct Link:
  • 35
    Moghaddam AA, Woodward M, Huxley R. Obesity and risk of colorectal cancer: a meta-analysis of 31 studies with 70,000 events. Cancer Epidemiol Biomarkers Prev 2007; 16: 253347.
  • 36
    Larsson SC, Wolk A. Obesity and colon and rectal cancer risk: a meta-analysis of prospective studies. Am J Clin Nutr 2007; 86: 55665.
  • 37
    Corley DA, Kubo A, Levin TR, et al. Abdominal obesity and body mass index as risk factors for Barrett's esophagus. Gastroenterology 2007; 133: 3441.
  • 38
    Edelstein ZR, Farrow DC, Bronner MP, Rosen SN, Vaughan TL. Central adiposity and risk of Barrett's esophagus. Gastroenterology 2007; 133: 40311.
  • 39
    Butterworth AS, Higgins JPT, Pharoah P. Relative and absolute risk of colorectal cancer for individuals with a family history: a meta-analysis. Eur J Cancer 2006; 42: 21627.
  • 40
    Castiglione G, Visioli CB, Zappa M, Grazzinib G, Mallardib B, Mantellinic P. Familial risk of colorectal cancer in subjects attending an organised screening programme. Dig Liver Dis 2012; 44: 803.
  • 41
    Card TR, Solaymani-Dodaran M, Hubbard R, Logan RFA, West J. Is an internal comparison better than using national data when estimating mortality in longitudinal studies? J Epidemiol Community Health 2006; 60: 81921.
  • 42
    Elwood M. Critical Appraisal of Epidemiological Studies and Clinical Trials. Oxford: Oxford University Press, 2007; 75117.
  • 43
    Machin D. Textbook of Clinical Trials. Chichester: John Wiley & Sons, 2006; 72931.